In order to test our hypothesis that metabolic dysregulation has an important role in PAH pathogenesis, in this new study performed on the same rat models, we examined alterations in the protein levels of Ngf, Nfe2l2, Slc2a1, and the restructuring of several metabolic pathways. This evidence concerns the gene NGF and pulmonary arterial hypertension.